Arkema Hikes China Resins Capacity
Arkema is to double capacity for its Sartomer UV curable resins at its Nansha plant in China. The French multinational chemical company said the expansion will support fast-growing demand in Asia for cutting-edge solutions in electronics, driven by 5G technology, and in renewable energies.
The additional output is scheduled to go on stream in the second half of 2023 and will supply customers in the Asia region.
“We are committed to continuously develop innovative materials and sustainable technologies to meet the robust demand driven by megatrends such as new technologies, clean mobility and urbanization. This new capacity will enable us to provide our latest innovative photocure resin solutions and tailored services to our customers and partners in Asia,” said Laurent Peyronneau, vice-president, coating solutions.
Earlier this month, Arkema announced a 50% expansion of global capacity for its Oleris advanced biomaterials, including C7, C11 and C18 materials, comprising n-heptanoic acid, n-heptaldehyde, undecylenic acid and Esterol A. These specialty chemicals are 100% derived from renewable castor seeds.
The new capacity, expected to start up in mid-2022, is part of Arkema’s previously announced bio-factory that is currently being built on Jurong Island, Singapore. Philippe Marthet, general manager for Oleris advanced biomaterials, said the Asian market is seeing strong demand for bio-based specialties.
Arkema’s bio-based oleochemicals are used in the cosmetics, fragrances & flavors, lubricants, construction and pharmaceutical industries.
Author: Elaine Burridge, Freelance Journalist
